Skip to main content
SpringerLink
Log in

Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs/systems with variable activities. We performed a retrospective study to investigate the relationship of clinical characteristics and complications with SLE activity in Chinese Han population. A cohort of 1,490 SLE inpatients was evaluated for disease activity using the systemic lupus erythematosus disease activity index (SLEDAI). Chi-square test or Fisher’s exact test was used to compare differences of clinical and laboratory features between active and inactive SLE patients. Logistic regression was chosen to explore the pattern of risk factors for disease activity. We found that neuropsychiatric involvement, nephritis, arthralgia, anti-dsDNA, serositis, hypocomplementemia, oral ulcerations, erythrocyte sedimentation rate, low C3, hematological abnormalities, and systolic pressure (1.010 < odds ratio < 10.568, 1.002 < 95% confidence interval < 31.599, 0.000 < P < 0.026) were major factors associated with disease activity, but not headaches, anti-ribonucleoprotein or anti-Sm, C-reactive protein, and anemia (P > 0.05, respectively). The involvements of urinary system, respiratory system, and central nervous system were significantly more frequent in active SLE than inactive SLE (0.000 < P < 0.014), except for alimentary system (P = 0.399). Our study has comprehensively evaluated the relationship of clinical characteristics and organs/systems involvement of SLE with SLEDAI in Chinese Han population and presented a compendium of factors affecting SLE, which should be useful for better evaluating disease activity and predicting organs/systems damage in SLE for clinical assessments and managements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  2. Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS (2004) The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31:1934–1940

    PubMed  Google Scholar 

  3. Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10:554–561

    Article  PubMed  CAS  Google Scholar 

  4. Prasad R, Ibanez D, Gladman D, Urowitz M (2006) Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 15:285–291

    Article  PubMed  CAS  Google Scholar 

  5. Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yague J, Cervera R, Ingelmo M, Font J (2004) Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 13:777–783

    Article  PubMed  CAS  Google Scholar 

  6. Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290–297

    Article  PubMed  CAS  Google Scholar 

  7. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276–279

    Article  CAS  Google Scholar 

  8. Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS (2007) Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford) 46:1471–1476

    Article  CAS  Google Scholar 

  9. Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155

    PubMed  CAS  Google Scholar 

  10. Vila LM, Alarcon GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2006) Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 55:799–806

    Article  PubMed  Google Scholar 

  11. Bertoli AM, Vila LM, Reveille JD, Alarcon GS (2008) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol 35:2355–2358

    Article  PubMed  Google Scholar 

  12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  13. Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S (2005) Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Rheumatology (Oxford) 44:873–878

    Article  CAS  Google Scholar 

  14. Wu O, Liu HH, Li WX, Zhang N, Wang Q, Li XP, Dong MX, Zhang XJ, Ye DQ (2008) Serum soluble nucleosome and the broad family of antinucleosome antibodies are associated with organ and tissue damage in systemic lupus erythematosus in a Chinese population. Clin Exp Dermatol 33:160–163

    Article  PubMed  CAS  Google Scholar 

  15. Petri M, Genovese M, Engle E, Hochberg M (1991) Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944

    Article  PubMed  CAS  Google Scholar 

  16. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397

    Article  PubMed  CAS  Google Scholar 

  17. Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424–432

    Article  PubMed  CAS  Google Scholar 

  18. Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86–94

    Article  PubMed  CAS  Google Scholar 

  19. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM (1988) Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47:918–923

    Article  PubMed  CAS  Google Scholar 

  20. Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum 35:1202–1210

    Article  PubMed  CAS  Google Scholar 

  21. Satoh M, Yamagata H, Watanabe F, Nakayama S, Ogasawara T, Tojo T, Akizuki M (1995) Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjogren’s syndrome. Lupus 4:63–65

    Article  PubMed  CAS  Google Scholar 

  22. Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469–475

    PubMed  CAS  Google Scholar 

  23. Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64:227–235

    Article  PubMed  CAS  Google Scholar 

  24. Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS (2003) Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage. Lupus 12:600–606

    Article  PubMed  CAS  Google Scholar 

  25. Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 45:191–202

    Article  PubMed  CAS  Google Scholar 

  26. Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ (2008) Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3:46–53

    Article  PubMed  CAS  Google Scholar 

  27. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914

    Article  PubMed  CAS  Google Scholar 

  28. Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A, Ramos-Remus C (2008) Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus. Lupus 17:1117–1121

    Article  PubMed  CAS  Google Scholar 

  29. Manzi S (2009) Lupus update: perspective and clinical pearls. Cleve Clin J Med 76:137–142

    Article  PubMed  Google Scholar 

  30. Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286

    Article  PubMed  Google Scholar 

  31. FitzGerald JD, Grossman JM (1999) Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. Lupus 8:638–644

    Article  PubMed  CAS  Google Scholar 

  32. Thumboo J, Lee HY, Fong KY, Chan SP, Chapman CA, Leong KH, Feng PH, Thio ST, Boey ML (2000) Accuracy of medical record scoring of the SLICC/ACR damage index for systemic lupus erythematosus. Lupus 9:358–362

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was partly supported by grants from the National Natural Science Foundation of China (30571608, 30771848) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20070366002). We are indebted to Dr Boke Zhang, the First Affiliated Hospital of Anhui Medical University, and Dr Guosheng Wang, Anhui Provincial Hospital, for assistance in case identification. We also thank Hang Hong, Wenhui Zhang, Changjuan Xu, and Guoping Chen, students of Anhui Medical University, for assistance in data collection. Their cooperation was invaluable to this research.

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, People’s Republic of China

    Lian Hong Li, Hai Feng Pan, Wen Xian Li & Dong Qing Ye

  2. Department of Rheumatology, Anhui Provincial Hospital, Hefei, People’s Republic of China

    Xiang Pei Li

  3. Department of Rheumatology, First Affiliated Hospital, Anhui Medical University, Hefei, People’s Republic of China

    Jian Hua Xu

Authors
  1. Lian Hong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hai Feng Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen Xian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiang Pei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian Hua Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong Qing Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong Qing Ye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, L.H., Pan, H.F., Li, W.X. et al. Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population. Clin Rheumatol 28, 1301–1307 (2009). https://doi.org/10.1007/s10067-009-1240-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1240-x

Keywords

Search

Navigation